organophosphonates has been researched along with meclofenamic acid in 1 studies
| Studies (organophosphonates) | Trials (organophosphonates) | Recent Studies (post-2010) (organophosphonates) | Studies (meclofenamic acid) | Trials (meclofenamic acid) | Recent Studies (post-2010) (meclofenamic acid) |
|---|---|---|---|---|---|
| 9,968 | 880 | 3,596 | 1,001 | 55 | 72 |
| Protein | Taxonomy | organophosphonates (IC50) | meclofenamic acid (IC50) |
|---|---|---|---|
| Prostaglandin G/H synthase 1 | Ovis aries (sheep) | 0.0675 | |
| Prostaglandin G/H synthase 1 | Homo sapiens (human) | 0.2115 | |
| Mitogen-activated protein kinase 1 | Homo sapiens (human) | 3.144 | |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | 0.1618 | |
| Prostaglandin G/H synthase 2 | Rattus norvegicus (Norway rat) | 0.1 | |
| Aldo-keto reductase family 1 member C3 | Homo sapiens (human) | 0.5307 | |
| Aldo-keto reductase family 1 member C2 | Homo sapiens (human) | 8.74 | |
| Aldo-keto reductase family 1 member C1 | Homo sapiens (human) | 2.3533 | |
| Prostaglandin G/H synthase 2 | Mus musculus (house mouse) | 0.164 | |
| Prostaglandin G/H synthase 1 | Rattus norvegicus (Norway rat) | 0.1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ibrahim, IN; Imig, JD; Kadowitz, PJ; Kaye, AD; Nossaman, BD; Smith, DE | 1 |
1 other study(ies) available for organophosphonates and meclofenamic acid
| Article | Year |
|---|---|
Effects of phospholipase A2, 12-lipoxygenase, and cyclooxygenase inhibitors in the feline pulmonary bed.
Topics: Animals; Arachidonate 12-Lipoxygenase; Arachidonic Acids; Blood Pressure; Cats; Cyclooxygenase Inhibitors; Drug Combinations; Enzyme Inhibitors; Estrenes; Female; Flavanones; Flavonoids; Lipoxygenase Inhibitors; Male; Meclofenamic Acid; Organophosphonates; Phosphodiesterase Inhibitors; Phospholipases A; Phospholipases A2; Pulmonary Circulation; Pyrrolidinones; Type C Phospholipases; Vasoconstriction; Vasoconstrictor Agents | 1997 |